Addison Advisors
AZN icon

Addison Advisors’s AstraZeneca AZN Stock Holding History

Addison Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$40K Buy
248
+8
+3% +$1.33K 0.02% 287
2026
Q2 		$45.5K Sell
240
-625
-72% -$118K 0.02% 258
2026
Q1 		$171K Sell
865
-3
-0.3% -$578 0.04% 241
2025
Q4 		$160K Buy
868
+32
+4% +$5.61K 0.04% 253
2025
Q3 		$128K Buy
836
+69
+9% +$10.4K 0.03% 282
2025
Q2 		$107K Sell
767
-121
-14% -$17K 0.03% 301
2025
Q1 		$130K Buy
888
+21
+2% +$3.04K 0.04% 262
2024
Q4 		$114K Sell
867
-5
-0.6% -$700 0.03% 283
2024
Q3 		$136K Buy
872
+93
+12% +$15K 0.04% 266
2024
Q2 		$121K Buy
779
+248
+47% +$37.3K 0.04% 265
2024
Q1 		$72K Buy
531
+33
+7% +$4.37K 0.02% 321
2023
Q4 		$67.1K Buy
498
+133
+36% +$17.3K 0.03% 317
2023
Q3 		$49.4K Buy
365
+116
+47% +$15.8K 0.02% 322
2023
Q2 		$35.6K Buy
249
+17
+7% +$2.5K 0.02% 358
2023
Q1 		$32.1K Sell
232
-19
-8% -$2.56K 0.02% 348
2022
Q4 		$34K Sell
251
-202
-45% -$25.3K 0.02% 321
2022
Q3 		$50K Buy
453
+16
+4% +$2.03K 0.03% 262
2022
Q2 		$58K Sell
437
-107
-20% -$14K 0.04% 242
2022
Q1 		$72K Buy
544
+267
+96% +$32K 0.04% 238
2021
Q4 		$32K Buy
277
+260
+1,529% +$30.6K 0.02% 283
2021
Q3 		$2K Buy
17
+8
+89% +$931 ﹤0.01% 371
2021
Q2 		$1K Buy
+9
New +$987 ﹤0.01% 376
2020
Q4 		$1K Buy
+9
New +$953 ﹤0.01% 361

Other funds holding AZN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $144B AUM 22.91% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return
SEB Asset Management
SEB Asset Management Stockholm $27B AUM
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Addison Advisors's AZN Position: Q3 2026 in Review

Addison Advisors increased its AstraZeneca (AZN) stake by 3.3% in Q3 2026, buying an estimated $1.33K and bringing the position to 248 shares worth $40K. The position accounts for 0.02% of the portfolio, ranked #287.

Addison Advisors first reported a position in AZN in Q4 2020 and has held it in 23 quarters since. The position peaked at $171K in Q1 2026. 918 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Addison Advisors held 248 shares of AstraZeneca worth $40K as of Q3 2026.
  • Addison Advisors bought 8 AstraZeneca shares in Q3 2026, an estimated $1.33K.
  • AstraZeneca made up 0.02% of Addison Advisors's portfolio in Q3 2026, its #287 holding.
  • Addison Advisors first reported a position in AstraZeneca in Q4 2020 and has held it in 23 quarters since.
  • Addison Advisors's AstraZeneca position peaked at $171K in Q1 2026.
  • 918 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Addison Advisors's 13F filing for Q3 2026, filed 6 Nov 2026.